Antiger Therapeutics Inc.
Saint Louis, MO · Biotech · Private
Soluble class II HLA fusion protein biologic that selectively depletes donor-specific antibody-producing B cells in transplant recipients
- Grants
- $869K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Class II Human Leukocyte Antigen biologics for antibody-mediated graft rejection. | $272,503 | |
| Federal grant | Department of Health and Human Services · Phase I · Peptide-HLA-DQ2 biologics for antigen-specific therapy in Celiac Disease | $293,680 | |
| Federal grant | Department of Health and Human Services · Phase I · Peptide-HLA-DQ8 biologics for antigen-specific therapy in Type 1 Diabetes | $303,274 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3253 | Percept Corp | — | $4.8M |
| 3254 | Cellarcus Biosciences, Inc. | — | — |
| 3255 | General Beverage Consulting & Management, Inc. | — | $350K |
| 3256 | Antiger Therapeutics Inc. | — | — |
| 3257 | ADVANCED RNA TECHNOLOGIES, LLC | — | — |
| 3258 | RESEARCH AND DIAGNOSTIC SYSTEMS, INC. | — | — |
| 3259 | CAVALRY BIOSCIENCES INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Class II Hla With Inter-chain Disulfide Bondapplication
- Class II Hla With Inter-chain Disulfide Bondapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.